H 2 S‐Amplified “Three‐in‐One” Antibacterial Strategy for Periodontitis Treatment Using a Photosensitive Pillararene‐Embedded COF/MOF Hybrid
Advanced Science · 2026-08 · 13 (43)
DOI: 10.1002/advs.75608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.05.2026. Verfasst von Shuang Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prosthodontics, Jilin Provincial Key Laboratory of Sciences and Technology for Stomatology Nanoengineering, School and Hospital of Stom…. Hauptthemen laut MEDLINE: Periodontitis, Anti-Bacterial Agents, Hydrogen Sulfide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jilin Provincial Science and Technology Department's Young Talent Training Program, Science and Technology Project of Jilin Province Financial Department.
Abstract (Originalsprache)
Reactive oxygen species (ROS)‐based nanomedicine holds great promise for combating biofilm‐associated infections (BAIs). Nonetheless, the strong antioxidant systems in these microenvironments lessen the effectiveness of ROS. The combination of ROS generation and depletion of antioxidant pathways is a potential approach to this issue. Herein, we present COF/HKUST‐10, a composite platform of a copper‐based metal‐organic framework (HKUST‐1) and pillararene‐embedded covalent organic frameworks for BAIs. Both endogenous hydrogen sulfide and exogenous light activate this platform, thereby inducing synergistic catalytic reactions that enhance ROS generation and local antioxidant inhibition. Transcriptomic analysis revealed that ROS and Cu + /Cu 2+ overload disrupted porphyrin metabolism in Porphyromonas gingivalis , severely impairing its energy metabolism and pathogenicity. This synergistic “three‐in‐one” antibacterial strategy involves ROS amplification, antioxidant system depletion, and copper ion‐mediated bactericidal effects. The experiments demonstrated the material's exceptional efficacy, resulting in robust antibacterial activity, efficient biofilm eradication, and significant reduction in inflammation. This study presents a distinctive strategy to enable synergistic treatment of BAIs, broadening the practical applications of supramolecular materials in biomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Prosthodontics, Jilin Provincial Key Laboratory of Sciences and Technology for Stomatology Nanoengineering, School and Hospital of Stomatology, Jilin University, Changchun, P. R. China.
- College of Chemistry, Jilin University, Changchun, P. R. China.
ORCID-Profile: Lin Wang
Förderung
- National Natural Science Foundation of China
- Jilin Provincial Science and Technology Department's Young Talent Training Program
- Science and Technology Project of Jilin Province Financial Department
- Interdisciplinary Innovation Team Project of Norman Bethune Health Science Department, Jilin University
Zitieren
APA
Liang, S., Li, M. H., Cheng, L., Zhang, T. S., Hui, H., Wang, Y., Zhang, H. P., Liu, B. W., Wang, L., & Yang, Y. W. (2026). H 2 S‐Amplified “Three‐in‐One” Antibacterial Strategy for Periodontitis Treatment Using a Photosensitive Pillararene‐Embedded COF/MOF Hybrid. Advanced Science, 13(43). https://doi.org/10.1002/advs.75608
Vancouver
Liang S, Li MH, Cheng L, Zhang TS, Hui H, Wang Y, et al. H 2 S‐Amplified “Three‐in‐One” Antibacterial Strategy for Periodontitis Treatment Using a Photosensitive Pillararene‐Embedded COF/MOF Hybrid. Advanced Science. 2026;13(43). doi:10.1002/advs.75608
BibTeX
@article{Liang2026,
author = {Liang, Shuang and Li, Meng-Hao and Cheng, Liang and Zhang, Tian-Shou and Hui, Hui and Wang, Yan and Zhang, Hong-Pu and Liu, Bo-Wen and Wang, Lin and Yang, Ying-Wei},
title = {H 2 S‐Amplified “Three‐in‐One” Antibacterial Strategy for Periodontitis Treatment Using a Photosensitive Pillararene‐Embedded COF/MOF Hybrid},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {43},
doi = {10.1002/advs.75608}
}
EUVIMED